TetraGraph Monitoring for Infants Undergoing Surgery
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the TetraGraph (TM) NMT Monitor treatment for infants undergoing surgery?
The research highlights the importance of accurate and reliable monitoring during surgery, which can improve patient outcomes by guiding therapy and reducing risks. Although specific data on the TetraGraph (TM) NMT Monitor is not provided, the general effectiveness of advanced monitoring technologies in improving surgical outcomes is supported by the studies.12345
Is TetraGraph Monitoring safe for infants undergoing surgery?
The available research does not specifically address the safety of TetraGraph Monitoring for infants undergoing surgery, but it highlights general concerns about sedation and anesthesia in children, such as the risk of neurotoxicity and respiratory issues. Continuous monitoring and advancements in technology have improved safety during sedation, but specific data on TetraGraph Monitoring is not provided.678910
How is the TetraGraph Monitoring treatment different from other treatments for infants undergoing surgery?
The TetraGraph Monitoring treatment is unique because it specifically monitors neuromuscular transmission (NMT) in infants during surgery, which helps ensure proper muscle relaxation and recovery. This is different from other treatments that focus on sedation or anesthesia without specialized monitoring of neuromuscular function.1112131415
What is the purpose of this trial?
The primary objective of this study is to evaluate the efficacy of train-of-four (TOF) monitoring using the TetraGraph Neuromuscular Transmission Monitor in pediatric patients less than 1 year of age and when feasible to compare it to standard TOF monitoring using a qualitative monitor.
Eligibility Criteria
This trial is for infants under 1 year old who are undergoing surgery. The study aims to include those who can safely undergo neuromuscular transmission monitoring during their procedure.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo train-of-four (TOF) monitoring using the TetraGraph Neuromuscular Transmission Monitor during surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- TetraGraph (TM) NMT Monitor
Find a Clinic Near You
Who Is Running the Clinical Trial?
Joseph D. Tobias
Lead Sponsor